BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haque W, Verma V, Fakhreddine M, Butler EB, Teh BS, Simone CB 2nd. Trends in Cardiac Mortality in Patients With Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2018;100:470-7. [PMID: 29353659 DOI: 10.1016/j.ijrobp.2017.10.031] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Brooks ED, Ning MS, Verma V, Zhu XR, Chang JY. Proton therapy for non-small cell lung cancer: the road ahead. Transl Lung Cancer Res 2019;8:S202-12. [PMID: 31673525 DOI: 10.21037/tlcr.2019.07.08] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
2 Jørgensen N, Meline EL, Jeppesen SS, Hansen O, Nielsen M, Schytte T. The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy. Acta Oncol 2019;58:1393-8. [PMID: 31271075 DOI: 10.1080/0284186X.2019.1629011] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Menon H, Guo C, Verma V, Simone CB 2nd. The Role of Positron Emission Tomography Imaging in Radiotherapy Target Delineation. PET Clin 2020;15:45-53. [PMID: 31735301 DOI: 10.1016/j.cpet.2019.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yegya-Raman N, Wang K, Kim S, Reyhan M, Deek MP, Sayan M, Li D, Patel M, Malhotra J, Aisner J, Marks LB, Jabbour SK. Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC. J Thorac Oncol 2018;13:1508-18. [PMID: 29883836 DOI: 10.1016/j.jtho.2018.05.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
5 Borkenhagen JF, Bergom C, Rapp CT, Klawikowski SJ, Rein LE, Gore EM. Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer. Clinical Lung Cancer 2019;20:435-41. [DOI: 10.1016/j.cllc.2019.05.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
6 Schlaak RA, SenthilKumar G, Boerma M, Bergom C. Advances in Preclinical Research Models of Radiation-Induced Cardiac Toxicity. Cancers (Basel) 2020;12:E415. [PMID: 32053873 DOI: 10.3390/cancers12020415] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
7 Sun X, Men Y, Wang J, Bao Y, Yang X, Zhao M, Sun S, Yuan M, Ma Z, Hui Z. Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Thorac Cancer 2021;12:1358-65. [PMID: 33728811 DOI: 10.1111/1759-7714.13908] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Xu T, Meng QH, Gilchrist SC, Lin SH, Lin R, Xu T, Milgrom SA, Gandhi SJ, Wu H, Zhao Y, Lopez-Mattei JC, Mohan R, Liao Z. Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiation Therapy-Induced Cardiotoxicity in Patients with Non-Small Cell Lung Cancer: A Secondary Analysis of a Prospective Randomized Trial. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)00905-6. [PMID: 34302893 DOI: 10.1016/j.ijrobp.2021.07.035] [Reference Citation Analysis]
9 Verma V, Fakhreddine MH, Haque W, Butler EB, Teh BS, Simone CB 2nd. Cardiac mortality in limited-stage small cell lung cancer. Radiother Oncol 2018;128:492-7. [PMID: 29934110 DOI: 10.1016/j.radonc.2018.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Amin NP, Desai N, Kim SM, Agarwal M, Amin NP. Cardiac Monitoring for Thoracic Radiation Therapy: Survey of Practice Patterns in the United States. Am J Clin Oncol 2020;43:249-56. [PMID: 31972567 DOI: 10.1097/COC.0000000000000666] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yin J, Zhao M, Lu T, Huang Y, Sui Q, Xi J, Lin Z, Xu S, Wang Q, Zhan C. Non–lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non–small cell lung cancer ≤2 cm: A propensity score analysis. J Surg Oncol 2019;120:1486-96. [DOI: 10.1002/jso.25724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Elhammali A, Blanchard P, Yoder A, Liao Z, Zhang X, Ronald Zhu X, Allen PK, Jeter M, Welsh J, Nguyen QN. Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer. Radiother Oncol 2019;136:136-42. [PMID: 31015115 DOI: 10.1016/j.radonc.2019.03.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
13 Demissei BG, Freedman G, Feigenberg SJ, Plastaras JP, Maity A, Smith AM, McDonald C, Sheline K, Simone CB 2nd, Lin LL, Carver JR, Liu P, Zhang L, Bekelman JE, Ky B. Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma. Int J Radiat Oncol Biol Phys 2019;103:851-60. [PMID: 30445173 DOI: 10.1016/j.ijrobp.2018.11.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
14 Zhang TW, Snir J, Boldt RG, Rodrigues GB, Louie AV, Gaede S, McGarry RC, Urbanic JJ, Daly ME, Palma DA. Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature. Int J Radiat Oncol Biol Phys 2019;104:582-9. [PMID: 30630029 DOI: 10.1016/j.ijrobp.2018.12.044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
15 Ibrahim EH, Baruah D, Budde M, Rubenstein J, Frei A, Schlaak R, Gore E, Bergom C. Optimized cardiac functional MRI of small-animal models of cancer radiation therapy. Magn Reson Imaging 2020;73:130-7. [PMID: 32866598 DOI: 10.1016/j.mri.2020.08.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Sarkar RR, Hatamipour A, Panjwani N, Courtney PT, Cherry DR, Salans MA, Yip AT, Rose BS, Simpson DR, Banegas MP, Murphy JD. Impact of Radiation on Cardiovascular Outcomes in Older Resectable Esophageal Cancer Patients With Medicare. Am J Clin Oncol 2021;44:275-82. [PMID: 33782335 DOI: 10.1097/COC.0000000000000815] [Reference Citation Analysis]
17 Hu ZG, Hu K, Li WX, Zeng FJ. Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion. PLoS One 2019;14:e0217007. [PMID: 31095610 DOI: 10.1371/journal.pone.0217007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Livingston K, Schlaak RA, Puckett LL, Bergom C. The Role of Mitochondrial Dysfunction in Radiation-Induced Heart Disease: From Bench to Bedside. Front Cardiovasc Med 2020;7:20. [PMID: 32154269 DOI: 10.3389/fcvm.2020.00020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
19 Boyce-Fappiano D, Nguyen QN, Chapman BV, Allen PK, Gjyshi O, Pezzi TA, De B, Gomez D, Lin SH, Chang JY, Liao Z, Lee P, Gandhi SJ. Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer. Clin Lung Cancer 2021:S1525-7304(21)00025-5. [PMID: 33707003 DOI: 10.1016/j.cllc.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ibrahim EH, Baruah D, Croisille P, Stojanovska J, Rubenstein JC, Frei A, Schlaak RA, Lin CY, Pipke JL, Lemke A, Xu Z, Klaas A, Brehler M, Flister MJ, Laviolette PS, Gore EM, Bergom C. Cardiac Magnetic Resonance for Early Detection of Radiation Therapy-Induced Cardiotoxicity in a Small Animal Model. JACC CardioOncol 2021;3:113-30. [PMID: 33912843 DOI: 10.1016/j.jaccao.2020.12.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Verma V, Choi JI, Simone CB 2nd. Proton therapy for small cell lung cancer. Transl Lung Cancer Res 2018;7:134-40. [PMID: 29876312 DOI: 10.21037/tlcr.2018.04.02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]